Seminor on accelerated stability testing of dosage forms sahil


Published on

  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Seminor on accelerated stability testing of dosage forms sahil

  2. 2. contents  Introduction  Types of Stability studies  Arrhenius equation  Steps involved in prediction of shelf life  Addition of Overages  Conclusion  References
  3. 3. INTRODUCTION  Stability of a pharmaceutical preparation is the capability of a formulation in a specific container-closure system to remain within its physical, chemical, microbiological, therapeutic and toxicological specifications throughout its shelf life.  The time during which the product retains the same properties and characteristics that it possessed at the time of manufacture.  Stability testing is used to: Provide evidence as to how the quality of the drug product varies with time.  Establish shelf life for the drug product. Determine recommended storage conditions. Determine container closure system suitability. Introduction
  4. 4. OBJECTIVES  To predict shelf life of product by accelerating rate of decomposition preferably by increasing the temperature.  To serve a rapid means of quality control.  To serve as a rapid means of selecting the best formulation from amongst a series of similar formulations of the product.  To predict the expiry date of product
  5. 5. Why Stability studies are necessary ?  Chemical degradation of the product leads to lowering of the concentration of the drug in the dosage form.  Toxic products may be formed , due to chemical degradation of the active ingredient.  Advantages of Stability studies Assurance to the patient Economic considerations Legal requirement
  6. 6.  According to ICH guidelines, The ambient study for drug product must be continued for a sufficient period of time beyond 12 months to cover the shelf life of the product.  Intermediate storage condition data are required when a significant change occurs prior to completion of study under the accelerated storage condition. The accelerated storage condition must be >15º C above the ambient storage conditions
  7. 7. Types of stability study Study Minimum time period covered by data at submission Storage condition Long term 25 C 30 C 2 C / 60% 2 C / 65% 5% r.h or 5% r.h. 12 months Intermediate 30 C 2 C / 65% 5% r.h. 6 months Accelerated 40 C 2 C / 75% 5% r.h. 6 months 7
  8. 8. LONG TERM STABILITY STUDIES  Study is performed at 250C/60% or 300C/ 65%.  Ideally 12 months data is to be generated but 6 months data is also acceptable in circumstances for submission of registration dossier, continued till end of shelf life.  For parenterals stability has to carried out at 2-80 C for drugs to be stored in freezer testing should be done at 200 C
  9. 9. ACCELERATED STABILITY STUDIES  Storage condition of 400C and relative humidity of 75% has been recommended for all the four zones for drug substances and drug products.  Studies carried out for 6 months.  Accelerated storage conditions must be at least 150C above the expected actual storage temperature and appropriate relative humidity
  10. 10. Testing Frequency:  For Long term testing: during first year sampling should be done every three months, during second year, sampling should be done every six months and after two years, sampling should be done once a year.  Accelerated testing : should be done atleast six months and it suggests sampling points of 0, 3, 6 months.
  11. 11.  Accelerated Stability study to predict the shelf life of the product, by accelerating the rate of decomposition, preferably by increasing the temperature of reaction conditions.  With the advancement in branch of kinetics, shelf life of a dosage form can be predicted within months based on accelerated stability reports Preparations are subjected to high stresses during stability testing.  Common high stresses include : Temperature Humidity Light
  12. 12. Arrhenius equation  It explains the effect of temperature on rate of a reaction.  According to Arrhenius, for every 10º rise in temperature, the speed of reaction increases about 2-3 times.  k = A e -Ea / RT  Arrhenius factor Energy of activation Ideal gas constant Log k = log A – Ea / 2.303 RT  Arrhenius factor is the frequency of molecular collisions occuring between the molecules.
  13. 13. Estimation of k value  The reaction is conducted at several temperatures. Concentration of reactants is determined.  Appropriate graphs are drawn for the kinetic data. Data is processed for all the orders. The order of the reaction is identified.  From the slopes of the lines, k values are calculated for all temperatures.
  14. 14. Estimation of energy of activation  A graph can be drawn by taking log k on y-axis and reciprocal temperature (1/T) on x-axis.  A straight line is obtained, the slope of the line is negative and the magnitude is Ea / 2.303 R.  The intercept corresponds to log A All the constants in the Arrhenius equation can be obtained from the graph.  Activation energy is the minimum energy that a molecule should possess so that the molecular collisions produce the product.
  15. 15. Steps involved in Accelerated Stability Testing Steps involved in prediction of shelf life  he Preparation is stored at different elevated temperatures,     to accelerate the degradation Samples are withdrawn at different time intervals The Order of the reaction is determined by plotting the appropriate function of concentration against time and linear relationship is determined Straight line in a graph permits the estimation of k value from the slope Similarly graphs are drawn for different elevated temperatures. K value for each temperature are calculated. By using Arrhenius relationship, Log k values are plotted against reciprocal of absolute temperature, energy of activation can be calculated.
  16. 16. Packaging material:in selecting packaging material, the following has to be considerd : Packaging material: in selecting packaging material, the following has to be considerd Packaging materials permeable to water vapor result in a falsification of the results for semisolid and liquid dosage forms if varying degrees of weight loss occur that leads to differences in the active ingredient concentration or ion strength. The use of inert standard packaging materials that are impermeable to water vapor is important precondition for stress tests that are evaluated in terms of reaction kinetics, and on the results on which stability predictions are to be tested.
  17. 17. Most of the stress tests are carried out in standard packaging material.The following standard packaging materials are used: •Most of the stress tests are carried out in standard packaging material. •The following standard packaging materials are used: •Solid dosage forms: 50-mL glass container with twist-off closure polypropylene tube •Semisolid dosage forms: Standard tube, small volumetric flask, Aluminum tube, inert internal lacquering • Liquid dosage forms: 25mL volumetric flask with ground-glass stopper However, furture investigations for the selection of the final packaging are necessary.
  18. 18. •Selection of packaging material for solid dosage forms. : •On the basis of the results of the stress tests for solid dosage forms, the sensitivity to moisture can be determined and suitable packaging materials can be selected. • As a rule, no interactions are to be expected. •If the final packaging material has been selected and samples packed in the final packaging material are available, the investigation of photostability should be performed. •Photostability :The samples with and without container are irradiated with a Xenon lamp for 24 hours.
  19. 19. Selection of packaging material for semisolid dosage forms 1. Selection of packaging material for semisolid dosage forms. Packaging: Aluminum tube internally lacquered, plastic tubes. 2. Problems: Corrosion , permeation, sorption. Tests packaging material – dosage form: To test for corrosion ,the filled metal tubes are stored horizontally upright and inverted at 400C, for 3 months and are then investigated. 3. To test for permeation and sorption the filled plastic tubes are stored for 3 months at 500C, 400C, 300C/70%. If the final packaging material has been selected, the investigations on the photostability are performed.
  20. 20. Selection of packaging material for liquid dosage forms :  Selection of packaging material for liquid dosage forms Packaging ampoule, injection vial with rubber stopper, glass bottle or plastic bottle with screw closure.  Problems: leakage. To test for permeation, and leakage, the finale formulation solution is filled in the container, and for desorption placebo solution is used.  The samples are stored vertically and inverted under 500C, 400C, 300C/70% for up to 12 weeks.  Tested intervals: 0, 1, 2, 3 months. If the final packaging material has been selected the investigations on the photostability are performed.
  21. 21. Accelerated Stability Testing in Emulsions  An emulsion is stored at elevated temperature.  This decreases viscosity of the continuous phase.  If the emulsion withstands this stress it is assumed to be     stable at normal conditions of storage. Centrifugation Method: Creaming and flocculation are slow processes. Centrifugation accelerates rate of creaming and flocculation in emulsions. The emulsion is subjected to different centrifugal speeds and separation of phases is observed at different time periods. Bad emulsion separates oil instantly. Good emulsion does not exhibit detectable separation of oil phase until certain time period.
  22. 22. Accelerated tests for Suspensions  Cake formation is accelerated by centrifugation.  High speed centrifugation is hence not preferred, low speed centrifugation is used to study the physical stability.  A Freeze-Thaw cycling technique is one of the stress testing .  This cycling treatment promotes particle growth and has primary importance for changes in absolute particle size, particle size distribution and crystal habit.
  23. 23. Accelerated Tests for moisture absorption  In this method, products are placed in an environment of high relative humidity and controlled temperature.  Their physical and chemical stabilities are assessed. The results will indicate whether the product is susceptible to moisture and also whether the container needs to provide a high degree of protection
  24. 24. Limitations  Stability predictions based on Arrhenius equation are valid only when the break down depends on temperature.  The energy of activation obtained in the study should be between 10 to 30 kcal/mole.  When degradation is due to Microbial contamination Photochemical reactions When the product looses its physical integrity at higher temperatures.  When the order changes at elevated temperatures. In case of disperse systems, when temperature is elevated viscosity is decreased and this may introduce errors in the prediction of stability.
  25. 25. ADDITION OF OVERAGES  Excess amount of the drug can be added to the preparation     to maintain 100% of the labelled amount during the shelf life of the product. Overages are calculated from the accelerated stability studies and added to the preparation at the time of manufacture. They should be within the limits compatible with the therapeutic requirement. Addition of overages doubles the shelf life of the product. Overages are added in multi vitamin preparations Addition of Overages
  26. 26. Conclusion  Knowledge of stability of a formulation is very important for three primary reasons: A Pharmaceutical product must appear fresh, elegant and professional for as long as it remains on the shelf.  Since some products are dispensed in multiple dose containers, uniformity of dose of the active ingredient over time must be ensured .  The active ingredient must be available to the patient through out the expected shelf life of the preparation.  A breakdown in the physical system can lead to non availability or of the medication to the patient.
  27. 27. References :  Martin’s Physical Pharmacy and Pharmaceutical Sciences.  Theory and practice of Industrial Pharmacy - Lechman  International Stability Testing Drug stability- Cartensen  C.V.S Subramaniyam 